Intro

This chapter explores a crucial clinical trial evaluating U-Petacitinib and L-Subrutinib for systemic lupus erythematosus. The discussion highlights the challenges in lupus trial design and the potential for these treatments to enhance patient outcomes in rheumatology.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app